Skip to content
Tuesday, March 28, 2023
Latest:
  • Debating Diets: What is the pescatarian diet?
  • Researchers pave the way for solutions to problems affecting preterm infants
  • Growing Up Baylor – DeBakey High School Edition: Dr. Lynda Chima Aririguzo
  • 6 tips to prevent colon cancer
  • TRISH to study how the human body and mind respond to spaceflight

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

Metastatic breast cancer

From The Labs 

Gene signature may give an upper hand in metastatic breast cancer

November 18, 2021November 18, 2021ER chimeric protein, ER gene translocations, estrogen receptor, Metastatic breast cancer, MOTERA, Research

A new strategy to refine breast cancer diagnosis could help guide a more precise selection of tumor-specific treatments.

Read more
From The Labs 

Interferon linked to ER+/HER- metastatic breast cancer resistance to therapy

March 12, 2021March 12, 2021CDK4/6 inhibitor therapy, endocrine therapy, ER+/HER2- breast cancer, Interferon, Metastatic breast cancer, Research, resistance to cancr treatment

Both preclinical models and tumor samples from patients with ER+/HER2- breast cancer link high IFN signaling to resistance to treatment.

Read more
From The Labs 

Becoming metastatic: how FOXA1 triggers metastatic behavior in breast cancer

January 16, 2020January 16, 2020endocrine resistant breast cancer, ER positive breast cancer, FOXA1, HIF-2a, Metastatic breast cancer, Research

About 75 percent of breast cancers have estrogen receptors, hence they are called estrogen receptor positive (ER+). Original ER+ breast cancer cells depend on estrogen

Read more
fuqua-lab
Momentum 

Understanding the importance of metastatic breast cancer research

October 17, 2018October 17, 2018Allison Mickey, Breast Cancer, Lester and Sue Smith Breast Center, Metastatic breast cancer, Research

You’ve likely seen a lot of information about the importance of breast cancer screenings and prevention this month. However, until recently, little was known about

Read more
From The Labs 

A new HER2 mutation leads to a clinical trial and to a promising diagnostic tool for metastatic breast cancer

July 27, 2017circulating tumor DNA, clinical trial, HER2 gene, Metastatic breast cancer, neratinib

There is a group of metastatic breast cancers that has the HER2 gene amplified – the cells have many copies of it – which leads

Read more

From the Labs Image of the Month

From The Labs Image of the Month From the Labs: a transparent heart

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951